Recombinant bovine immunodeficiency virus gag virus-like particles containing influenza immunogens
US11576965B2 · kind B2 · utility
1Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2016 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | Jul 1, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein, are Bovine immunodeficiency virus gag protein (“Bgag”) recombinant virus like particles (“VLPs”) including one or more different types of target pathogen proteins. Also described, are compositions including the Bgag VLPs and the methods of making and using the novel Bgag VLP.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.